Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain
Hyperactive mutation V617F in the JAK2 regulatory pseudokinase domain (JH2) is prevalent in patients with myeloproliferative neoplasms. Here, we identified novel small molecules that target JH2 of JAK2 V617F and characterized binding via biochemical and structural approaches. Screening of 107,600 sm...
Saved in:
Main Authors: | Anniina T. Virtanen (Author), Teemu Haikarainen (Author), Parthasarathy Sampathkumar (Author), Maaria Palmroth (Author), Sanna Liukkonen (Author), Jianping Liu (Author), Natalia Nekhotiaeva (Author), Stevan R. Hubbard (Author), Olli Silvennoinen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>IRF2BP2</i> Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia
by: Maaria Palmroth, et al.
Published: (2021) -
The pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation
by: Haixia Xu, et al.
Published: (2019) -
The pseudokinase TRIB3 controls adipocyte lipid homeostasis and proliferation in vitro and in vivo
by: Miguel Hernández-Quiles, et al.
Published: (2023) -
Adipocyte-specific tribbles pseudokinase 1 regulates plasma adiponectin and plasma lipids in mice
by: Elizabeth E. Ha, et al.
Published: (2022) -
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain
by: Elena Gabriele, et al.
Published: (2017)